ArticlebioRxiv : the preprint server for biology2024

Endocrine persistence in ER+ breast cancer is accompanied by metabolic vulnerability in oxidative phosphorylation.

Steven Tau et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.